by Dan Roberts November 2006 Some people have been reporting considerable pain and/or conjunctival hemorrhaging (eye redness) following intraocular injections of anti-angiogenic drugs (Macugen, Lucentis and off-label Avastin) for wet AMD. Most patients, however, are reporting nothing more than some discomfort. The following information has been gathered from patients who have undergone the procedure. In [Read More]
News
Exercise May Protect Against Wet AMD
by Dan Roberts November 2006 A study at the University of Wisconsin has shown that regular exercise may help to prevent the wet form of age-related macular degeneration (AMD). As reported in the November 2006 issue of British Journal of Ophthalmology, the study monitored almost 4,000 people between the ages of 43 and 86 over [Read More]
Drusen Lasering
by Dan Roberts (Updated 11/4/06) Drusen are thought to be fatty waste products from the photoreceptor cells. They often appear on the macula (the center of the retina) in the early stages of Macular Degeneration, and they can cause gradual loss of central vision. “Hard” drusen are common in aging eyes, and do not necessarily [Read More]
Cataracts as a Complication of Retinal Surgery
by Wendy Strouse Watt, O.D. October 2006 Cataracts are a complication commonly associated with any retinal or vitreal surgery. When cells are released during surgery, they can attach to the back of the lens and grow, or proliferate, accelerating cataract changes. Many surgeons do double or triple procedures when doing retinal or vitreous surgery. An [Read More]
Discovery of HTRA1 Gene Provides Potential Marker for AMD
by Dan Roberts October 2006 The protein Complement Factor H (CFH) has previously been found to play a role in the development of soft confluent drusen leading to AMD (see “CFH and CFB Proteins May Lead to AMD”). CFH has implicated inflammation as part of the AMD pathogenesis, and now, discovery of a new gene [Read More]